By being vertically integrated and owning all steps of the pharmaceutical development and production process, Accord can bring high quality medicines to patients faster, more economically and with greater efficiency.

Accord has one of the most dynamic product pipelines in the pharmaceutical industry. We already have a portfolio of over 120 molecules across multiple therapeutic classes. We are committed to build up this number to compete with the largest product ranges in the sector.

Accord has a particular focus on ensuring the safe use of our products, both for patients and medical professionals.

Accord's portfolio comprises a multitude of different pharmaceutical forms, including; tablets (standard, film- coated, effervescent, sustained release, cytotoxic and immunosuppressant), capsules, cytotoxic injectables (powders and solution vials), non- cytotoxic (ampoules) and INCB controlled drugs.

South African Marketing Authorisations

Cardiovascular

Amlodipine
Losartan Potassium and HTCZ
Pravastatin Na

Anti-Diabetes and Endocrine

Finasteride
Glimepiride
Metformin HCl
Pioglitazone

Musculo-Skeletal 

Alendronate Na

Central Nervous System

Escitalopram
Midazolam
Naltrexone
Risperidone
Ropinirole

Dermatology

Vitamin A and D Ointment

Supplements

Calcium
Calcium and Vitamin D

Gastro-Intestinal Tract

Omeprazole

Oncology

Anastrozole
Bicalutamide 
Carboplatin
Cisplatin

Epirubicin 
Finasteride
5 - Fluorouracil
Docetaxel

Irinotecan
Gemcitabine 
Letrozole
Methotrexate

Ondansetron
Oxaliplatin
Paclitaxel
Temozolomide

Vincristine